β-catenin expression in relation to genetic instability and prognosis in colorectal cancer

Oncology Reports

Volumn 17, Issue 2, 2007, Pages 447-452

  Mårtensson, Ann ^a   Öberg, Åke ^a   Jung, Andreas ^b   Cederquist, Kristina ^a   Stenling, Roger ^a   Palmqvist, Richard ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Colorectal cancer; Genetic instability; Prognosis; catenin

Indexed keywords

BETA CATENIN; MICROSATELLITE DNA; WNT PROTEIN;

AGED; ARTICLE; BIOSYNTHESIS; COLORECTAL TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MICROSATELLITE INSTABILITY; MIDDLE AGED; PLOIDY; PROGNOSIS; SIGNAL TRANSDUCTION;

AGED; AGED, 80 AND OVER; BETA CATENIN; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE REPEATS; MIDDLE AGED; PLOIDIES; PROGNOSIS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 33947733010     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.2.447     Document Type: Article

References (36)

1. Tomlinson I, Ilyas M and Novelli M: Molecular genetics of colon cancer. Cancer Metastasis Rev 16: 67-79, 1997. (Pubitemid 27219471)
2. Fernebro E, Halvarsson B, Baldetorp B, et al: Predominance of CIN versus MSI in the development of rectal cancer at young age. BMC Cancer 2: 25, 2002.
3. Tomlinson I and Bodmer W: Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nat Med 5: 11-12, 1999. (Pubitemid 29050986)
4. Rajagopalan H, Nowak MA, Vogelstein B, et al: The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer 3: 695-701, 2003. (Pubitemid 37328824)
5. Lengauer C, Kinzler KW and Vogelstein B: Genetic instabilities in human cancers. Nature 396: 643-649, 1998. (Pubitemid 29003936)
6. Shimizu Y, Ikeda S, Fujimori M, et al: Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability. Genes Chromosomes Cancer 33: 73-81, 2002.
7. Lengauer C, Kinzler KW and Vogelstein B: Genetic instability in colorectal cancers. Nature 386: 623-627, 1997. (Pubitemid 27175430)
8. Brabletz T, Jung A and Kirchner T: Beta-catenin and the morphogenesis of colorectal cancer. Virchows Arch 441: 1-11, 2002.
9. Morin PJ: beta-catenin signaling and cancer. Bioessays 21: 1021-1030, 1999.
10. Jass JR, Young J and Leggett BA: Evolution of colorectal cancer: change of pace and change of direction. J Gastroenterol Hepatol 17: 17-26, 2002. (Pubitemid 34304382)
11. Henderson BR, Galea M, Schuechner S, et al: Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1. J Biol Chem 277: 24258-24264, 2002. (Pubitemid 34951943)
12. Bienz M: The subcellular destinations of APC proteins. Nat Rev Mol Cell Biol 3: 328-338, 2002.
13. Takahashi M, Tsunoda T, Seiki M, et al: Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. Oncogene 21: 5861-5867, 2002. (Pubitemid 35007236)
14. Cullingworth J, Hooper ML, Harrison DJ, et al: Carcinogen-induced pancreatic lesions in the mouse: effect of Smad4 and Apc genotypes. Oncogene 21: 4696-4701, 2002. (Pubitemid 34833147)
15. Wang HL, Wang J, Xiao SY, et al: Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin. Int J Cancer 101: 301-310, 2002. (Pubitemid 34983184)
16. Soussi T: The p53 tumour suppressor gene: from molecular biology to clinical investigation. Ann NY Acad Sci 910: 121-137, 2000.
17. Jass JR, Barker M, Fraser L, et al: APC mutation and tumour budding in colorectal cancer. J Clin Pathol 56: 69-73, 2003. (Pubitemid 36132478)
18. Gafa R, Maestri I, Matteuzzi M, et al: Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability. Cancer 89: 2025-2037, 2000.
19. Baas IO, Mulder JW, Offerhaus GJ, et al: An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 172: 5-12, 1994. (Pubitemid 24074995)
20. Vindelof LL, Christensen IJ, Nissen NI, et al: A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323-327, 1983. (Pubitemid 13087609)
21. Boland CR, Thibodeau SN, Hamilton SR, et al: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-5257, 1998.
22. Lamlum H, Papadopoulou A, Ilyas M, et al: APC mutations are sufficient for the growth of early colorectal adenomas. Proc Natl Acad Sci USA 97: 2225-2228, 2000. (Pubitemid 30134050)
23. Bondi J, Bukholm G, Nesland JM, et al: Expression of non-membranous beta-catenin and gamma-catenin, c-Myc and cyclin D1 in relation to patient outcome in human colon adenocarcinomas. APMIS 112: 49-56, 2004. (Pubitemid 38297167)
24. Cheah PY, Choo PH, Yao J, et al: A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1. Cancer 95: 2479-2486, 2002. (Pubitemid 35424032)
25. Baldus ES, Mönig PS, Huxel S, et al: MUC1 and nuclear β-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res 10: 2790-2796, 2004. (Pubitemid 38509157)
26. Roca F, Mauro VL, Bonadeo F, et al: Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9) and TIMPs (1 and 2) in patients with colorectal carcinoma. J Surg Oncol 93: 151-160, 2006. (Pubitemid 43235262)
27. Cianchi F, Messerini L, Palomba A, et al: Character of the invasive margin in colorectal cancer: does it improve prognostic information of Dukes staging? Dis Colon Rectum 40: 1170-1175, 1997.
28. Park KJ, Choi HJ, Roh MS, et al: Intensity of tumor budding and its prognostic implications in invasive colon carcinoma. Dis Colon Rectum 48: 1597-1602, 2005.
29. Palmqvist R, Rutegard JN, Bozoky B, et al: Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumour clusters. Am J Pathol 157: 1947-1953, 2000.
30. Ueno H, Murphy J, Jass JR, et al: Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40: 127-132, 2002. (Pubitemid 34122114)
31. Brabletz T, Jung A, Hermann K, et al: Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract 194: 701-704, 1998. (Pubitemid 28523944)
32. Chung GG, Provost E, Kielhorn EP, et al: Tissue microarray analysis of β-catenin in colorectal cancer shows nuclear phospho-β-catenin is associated with a better prognosis. Clin Cancer Res 7: 4013-4020, 2001. (Pubitemid 34044621)
33. Kapiteijn E, Liefers GJ, Los LC, et al: Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol 195: 171-178, 2001. (Pubitemid 32899025)
34. Tomlinson I: Different pathways of colorectal carcinogenesis and their clinical pictures. Ann NY Acad Sci 910: 10-18, 2000.
35. Sparks AB, Morin PJ, Vogelstein B, et al: Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58: 1130-1134, 1998. (Pubitemid 28183198)
36. Miyaki M, Iijima T, Kimura J, et al: Frequent mutation of betacatenin and APC genes in primary colorectal tumours from patients with hereditary nonpolyposis colorectal cancer. Cancer Res 59: 4506-4509, 1999. (Pubitemid 29428947)